The Board of Directors of Glenmark Pharmaceuticals Limited at its meeting held on 24th May, 2024, recommended Dividend at 250% i.e. INR 2.5/- per share (face value of INR 1/- each) on the Equity Share Capital of the Company for the financial year 2023-24 subject to the approval of the Shareholders at the up coming Annual General Meeting.